Skip to main content
OpenTrials

Clinical trial condition

Recurrent Small Cell Lung Carcinoma

Explore clinical trials studying Recurrent Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Small Cell Lung Carcinoma trial results

Completed

A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

NCT00887159

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Carcinoma, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 301 locations
View Trial Details
Completed

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

NCT01533181

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions